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ABSTRACT 
This work aims to evaluate the usefulness of powdered milk as a vehicle of drugs for 
direct compression into mini-tablets specifically designed for the pediatric population.  
A 2
3
 full factorial design was carried out to identify the effect of selected variables and 
their interactions (paracetamol to milk ratio, fraction of disintegrant and compression 
force), on selected responses (weight variation, thickness and tensile strength of minitablets 
and dissolution time of paracetamol) of the mini-tablets. Tablets were manufactured 
according to a matrix design resulting in eight combinations of four different tableting 
formulations compacted at two distinct forces. Each batch of tablets was evaluated for 
thickness (n=6), uniformity of weight (n=20), diametric crushing strength and tensile 
strength (σ) (n=6) and dissolution testing (n=12). A stepwise multiple linear regression was 
used to identify and quantify the relationships between each response and the variables 
studied and their interactions. Results were analyzed by ANOVA to identify the significant 
variables and variable interactions responsible for the effects observed. 
The increase on milk fraction in the formulation improved the compressibility of 
paracetamol with a decrease on weight variation. Thinner and harder compacts with slower 
paracetamol releases were also obtained. These observations were not surprising if 
powdered milk composition is taken into consideration: milk proteins, lactose (widely used 
as diluent) and lipids (often used as binders, lubricants and taste masking agents), which 
individually or in combination contribute to easier the production of tablets. A marked 
decrease on the dissolution time was observed as sodium croscarmellose was added to the 
milk rich formulations, as anticipated. The increase of the compression force was reflected 
by the production of thinner compacts with slightly higher tensile strengths but little effect 
on the dissolution median time. At high forces it was often observed a higher crushing 
strength and an increase of the importance of particle deformation in disintegration time.  
The study has proved the viability of using powdered milk on the production of 
minitablets to the delivery of drugs. The experimental design and statistical analysis 
enabled the identification of the most significant variables and their interactions affecting 
the properties of the mini-tablets, particularly the milk/paracetamol ratio which proved to 
be critical for the proprieties of the final product. 
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1. INTRODUCTION   
In recent years the publication of numerous guidelines in the area of pharmaceutical 
development of medicines for pediatric use [1-3] has increased awareness and promoted 
research in the field. These guidelines also point out that solid dosages forms are preferable 
when developing new medicines for children. The later may pose a challenge considering 
that pediatrics represent a very heterogeneous group in need of individualized dosing and 
ease of administration palatable medicine, reason why small flexible solid dosage forms as 
mini-tablets are an attractive choice when developing new solid dosage forms for children 
[4, 5].  Lennartz and Mielck [6] described mini-tablets as tablets with a diameter equal or 
smaller than 2-3 mm, however the age of the child able to swell this tablets remains 
inconclusive.  Recent evidence showed that round uncoated tablets are well accepted by 1 
to 4 year old children [7], while other studies deemed safe their usage in children as young 
as 2 years old [4]. Furthermore, is important to keep in one’s mind that when developing 
new solid dosage forms for children a careful consideration of the to be used excipients 
must be done.  Excipients that are innocuous, when used in adults may pose a threat to the 
different age groups within pediatrics [8] therefore a complete, universally accepted food 
component used in children’s diet since birth, would be an innovative and attractive 
excipient in formulating dosage forms for the mentioned population.  
The primary function of milk is to meet the complete nutritional requirements of the 
child making it a nutrient dense food. The recognition of milk’s richness in nutrients that 
play a key-role in human physiology has in recent years led to a wide variety of novel 
application in dairy technology [9]. In this work paracetamol ,a worldwide well-known 
analgesic drug, was chosen as a model drug because of its essential role in the relive of pain 
and palliative care of children [10]. 
Often times when developing new dosage forms an experimental design approach is  
used,  in order to efficiently extract the most useful information possible from experimental 
results using a small number of trials, minimizing costs, saving time and improving the 
properties of the resulting products [11]. As so, it is crucial to identify the variables that 
affect the most the quality of the product obtained. In this study a full factorial design [12] 
was employed to identify the variables (both formulation and manufacturing) and their 
interactions with significant impact on selected properties of mini-tablets made of 
paracetamol and powder milk produced by direct compression. 
2. MATERIALS AND METHODS 
2.1 Materials 
Whole milk powder (Nido®, Nestlé Portugal, Oeiras, Portugal), paracetamol (Lusifar, 
Lisbon, Portugal), sodium croscarmellose (Ac-Di-Sol®, FMC BioPolymer, Philadelphia, 
USA), D-mannitol (Carlo Erba,Cornaredo, Italy) and magnesium stearate (Sigma-Aldrich, 
Munich, Germany) were used in the different mini-tablets formulations. 
2.2 Experimental design and statistical analysis 
To investigate the properties of the mini-tablets, a design of experiments approach was 
considered. The design was constructed based on previous experiments (results not shown) 
which have shown that the milk/drug ratio and disintegrant fraction and the compression 
force were critical to the manufacture of the mini-tablets. The influence of the independent 
variables (milk/paracetamol ratio, disintegrant fraction and compression force) and their 
interactions on mini-tablets’ weight and thickness variations, tensile strength and 
paracetamol dissolution rate were evaluated using a 2
3
 full factorial design, as described in 
Table 1. 
Table 1. Independent variables and their levels in the full factorial design. 
Factor Variables 
Levels 
Low (-) High (+) 
Milk / Paracetamol ratio m/M 20/80 80/20 
Disintegrant (%) d/D 1 5 
Compression pressure (GPa) f/F 73 178 
 
Statistical analysis was performed using an IBM SPSS Statistics version 22.0 for 
windows (IBM Corporation, Endicott, NY, USA). Results were analyzed by ANOVA to 
identify the significant (p<0.05) variables and variables’ interactions and their impact on 
the properties of the mini-tablets. The analysis proceeded by application of multiple linear 
regression to identify the relationships between each response and the studied variables and 
their respective interactions [13, 14]. The inclusion or exclusion of variables in the 
equations was based on the significance (p<0.05) of each variable. Furthermore, the best 
models were chosen after careful examination of the residuals (expressed as the root mean 
square error, RMSE), adjusted coefficient of correlation (R
2
Adj), mean square error (MSE) 
and significance based on the F-test [15]. 
2.3 Formulation and production of the mini-tablets 
Tablets were manufactured according to the design matrix (Table 2) resulting in eight 
combinations of four different tableting formulations compacted, using two distinct forces. 
Powder milk, paracetamol, mannitol and sodium croscarmellose were weighted and 
blended in a cube mixer (Erweka, Heusenstamm, Germany) for 10 min, prior to the 
addition and mixing of magnesium stearate for another 5 min. All formulations were 
subject to a compression rate of 5 mm/min in a mechanical press (LR 50K,Lloyds 
Instruments, Leicester, UK) equipped with flat faced punches and dies (2.5 mm diameter). 
Different compression forces of 3, 5 and 7 kN correspondent to 76, 127 and 178 GPa, were 
applied. Each experiment was carried out twice.   
Table 2. Complete matrix for the full factorial design 
Factors
a)
 
Variables' Levels Variables' Interactions
b)
 
M D F MD MF DF MDF 
mdf - - - + + + - 
Mdf + - - - - + + 
mDf - + - - + - + 
MDf + + - + - - - 
mdF - - + + - - + 
MdF + - + - + - - 
mDF - + + - - + - 
MDF + + + + + + + 
 
 
 
2.4 Characterization of the mini-tablets 
Uniformity of weight: The uniformity of weight of the mini-tablets (n=20) was carried 
out according to British Pharmcopoeia [16] using an analytical balance (Mettler-Toledo 
AG204DR, Columbus, OH, USA);  
Tensile strength and thickness: All mini-tablets were stored at least two weeks at room 
temperature (21C) and relative humidity (RH=65%) prior to evaluation. Tablets (n=6) of 
each batch were evaluated for thickness (calipers) and diametric crushing strength(Texture 
Analyzer, TA-XT Plus, Stable Micro Systems, Godalming, UK, at a constant rate of 0.5 
mm/s). Results from the crushing test were also analyzed for tensile strength (σ) [17];  
Dissolution test: The evaluation of the release of paracetamol from the mini-tablets was 
carried out by dissolution tests (n=12) in conformity with the British Pharmacopoeia [16] 
(paddle apparatus, at 50 rpm in phosphate buffer solution, pH=5.8,Sotax AT7, Sotax AG, 
Allschwil, Switzerland). The quantification of paracetamol in the samples was carried out 
by high pressure liquid chromatography (HPLC, Merck–Hitachi LabChrom,L-7100pump, a 
a) 
m/M, d/D and f/F represent milk content, sodium croscarmellose content and compression pressure at 
low and high levels, respectively. 
b) 
To obtain signs for interaction terms in combination, multiply signs of factors. 
L-7200 auto-sampler and a L-7450 diode array detector, Tokyo, Japan) with a C-18 
reverse-phase column (Purospher®, Merck, Darmstadt, Germany) once the method was 
validated (results not shown). 
3. RESULTS  
Table 3. Results for different properties of mini-tablets according to the 2
3 
factorial design
a)
 
Factors 
Uniformity of 
weight 
(mg) 
Thickness 
(mm) 
Tensile Strength 
(N/mm
2
) 
Mean dissolution 
time 
 (t50/min) 
mdf 11.68 ±0.65 2.14 ± 0.07 0.35 ± 0.18 2.1 ± 0.08 
Mdf 12.10 ± 0.39 1.99 ± 0.06 0.89 ± 0.37 15.48 ± 2.11 
mDf 11.81 ± 0.54 2.14 ± 0.07 0.13 ± 0.10 1.94 ± 0.24 
MDf 11.95 ± 0.60 2.01 ± 0.06 0.91 ± 0.31 5.12 ± 1.22 
mdF 11.76 ± 0.57 2.04 ± 0.05 0.37 ± 0.21 1.88 ± 0.26 
MdF 11.99 ± 0.48 1.96 ± 0.05 0.97 ± 0.26 15.58 ± 0.71 
mDF 11.90 ± 0.64 2.05 ± 0.07 0.22 ± 0.18 2.05 ± 0.06 
MDF 11.89 ± 0.45 1.96 ± 0.06 0.96 ± 0.24 5.40 ± 0.94 
 
 
3.1 Experimental Design  
The variables and levels of variables were selected based on previous experiments 
(results not shown) for the production of mini-tablets for pediatric delivery of paracetamol. 
In order to understand the potential use of milk as vehicle for the delivery of drugs a 
stepwise procedure was considered to understand the performance of the mini-tablets 
maximizing the significance of the selected variables. 
3.1.1 Uniformity of weight 
Table 3 shows that all batches complied with the British Pharmacopoeia specifications 
for uniformity of mass for single dose preparations [16].  Statistical results (Table 4) show a 
positive correlation between increasing quantities of powdered milk, 'M', in the formulation 
and mini-tablets weight, as for the increase in disintegrant percentage ('D') and 
compression load ('F') both showed to have a minimum negligible or no effect on the 
studied response.  It was also possible to discern that the addition of higher fractions of 
a)
 Uniformity of weight n=20, thickness and tensile strength n= 6, Mean dissolution time n=3 
 
sodium croscarmellose to milk rich formulations, 'MD', lead to an adverse effect on 
batches' weight.  A similar effect is found, when higher compression forces were applied to 
milk rich formulations, 'MF'. Finally, the interaction of both the 'D' and 'F' variables and 
interaction of the former with the milk/paracetamol ratio, 'M' produced a minimum 
imperceptible effect on mini-tablets' weight.  
Statistical approach showed that for the relationship between the above described effects 
and the studied response the only significant effects are milk/paracetamol ratio, ‘M’ and the 
interaction between the former and the disintegrant fraction, ‘MD’. Therefore, mini-tablets’ 
weight can be described by the reduced equation Eq (1) (RMSE = 0.523, R
2
Adj =0.039, 
MSE= 0.273, F=8.222).   
                                                                           Eq(1)                                                                                   
3.1.2. Thickness  
Analyzing Tables 3 and 4 it’s possible to see that the increase of powdered milk, 'M', on 
the formulations and the use of higher compression loads, 'F', clearly produced thinner 
compacts.  Contrastingly, the increase of 'D' showed a very small almost imperceptible 
incrementing effect on compacts’ thickness.  As for the formulations containing higher 
powdered milk loads it was possible to determine that the addition of increasing 
disintegrant percentages produced no effect whatsoever ('MD'), but that increasing 
compression forces caused a distinguishable antagonistic positive effect on compacts' 
thickness, 'MF'. When increasing compression loads are applied to sodium croscarmellose 
rich formulations no discernable effect is found. Finally, a small negative effect was 
observed, when the levels of all three variables were increased ('MDF').  
Results show that the only statistically significant variables are milk/paracetamol ratio, 
‘M’, the compression force ‘F’ and the interaction between the two ‘MF’. Consequently, 
the correlation between thickness and the studied variables can be described by the reduced 
equation Eq(2) (RMSE = 0.063, R
2
Adj = 0.498, MSE= 0.004, F=36.325).   
MFFMmmThickness 014.0034.0056.0029.2)(                                                       Eq(2) 
3.1.3 Tensile Strength 
The crushing resistance test and, consequently, tensile strength results (Table 3 and 4) 
demonstrated that the addition of increasing powdered milk quantities, 'M', to the to be 
compressed formulations produced a huge raise in mini-tablet's mechanical strength. A 
similar however, much smaller positive effect on compacts strength was discernable, when 
increasing compression loads ('F') were applied. On the other hand, weaker compacts were 
produced when higher fractions of sodium croscarmellose, 'D', were used it lead to the 
production of weaker compacts. When higher fractions of disintegrant were added to 
powdered milk rich formulations ('MD)', the former had a favourable impact in compacts' 
mechanical strength, when high loads were applied to this same formulations ('MF') a 
similar, however very small positive effect was also produced. A slightly more pronounced 
positive effect is detected when increasing forces are applied to compress formulations 
containing greater sodium croscarmellose percentages, 'DF'.  Finally and surprisingly, the 
MDMmgWeight 064.0111.0888.11)( 
simultaneously increase of all three variables, 'MDF' caused a small antagonistic negative 
effect on the produced compacts.   
 Statistical analysis of the results indicates that the only significant effect is the 
milk/paracetamol ratio ‘M’ one,  as so mini-tablets tensile strength can be modeled by the 
reduced following equation Eq. (5) (RMSE = 0.233, R
2
Adj = 0.646, MSE= 0.055, 
F=196.486): 
 MmmNStrengthTensile 334.0599.0)(
2                                                                          Eq(3) 
Statistical analysis also shows that milk/paracetamol ratio coefficient is tremendously 
significant, so it’s no surprise to have observed such a striking difference between tensile 
strengths of mini-tablets with more paracetamol and the ones with a higher percentage of 
milk (Table 3).  
3.1.4. Mean dissolution time 
Results (Table 3) from the performed dissolution tests show that when comparing milk 
rich tablets with the ones with higher fraction of paracetamol, the former disintegrate at a 
much slower rate, furthermore a significant difference is observed when 1% or 5% of 
disintegrant was used. When a higher fraction of croscarmellose sodium is used a t50 of 5-8 
is obtained whereas smaller fractions of disintegrant result in t50 of 14-16 min. Mini-tablets 
containing more paracetamol disintegrated almost instantly resulting in more than 90% 
drug release within the first 2 minutes of test. Notwithstanding, even the batches with the 
slowest dissolution profiles showed 80% drug release after 40 minutes, complying with the 
British pharmacopeia monograph for paracetamol tablets [16]. 
 Analysis of coefficient statistics (Table 4) supports the findings described above. 
Greater fractions of powdered milk, 'M', in the formulations increased the t50, delaying the 
mini-tablets' dissolution.  Contrastingly, the presence of higher fractions of sodium 
croscarmellose, 'D', decrease t50, promoting a quicker desintegration of the tablets.  As for 
the manufacture variable, 'F' a very small increase in the dissolution rate is observed when 
higher compression forces were used. Equally, to the sole increase of 'D' a marked decrease 
in the mean dissolution time was detected, when higher percentages of disintegrant are 
present in the formulation of milk rich mini-tablets. The interaction between 'F' and 'M' and 
'F' and 'D', shows an increasing small in t50. Finally, the interaction between the three 
variables ('MDF') causes a minimum decrease in mini-tablets’ dissolution time.  
The linear regression rendered statistically significant the influence of milk/paracetamol 
ratio, percentage of disintegrant and the interaction between the two. Accordingly, the t50 
can be traduced by the following reduced equation Eq(4) (RMSE = 1.120, R
2
Adj = 0.952, 
MSE = 1.252, F= 241.756). 
MDDMt 566.2572.2199.4139.6(min)50                                                                   Eq(4) 
Eq(4) significantly describes mini-tablets disintegration behaviour, seeing as the main 
effects in it account for the almost totality of the different phenomenon occurring during 
dissolution test (R
2
Adj=0.967).  
Table 4. Evaluation of the results for different properties of the mini-tablets made by ANOVA. 
Factors 
Uniformity of 
weight 
(mg) 
Thickness  
(mm) 
Tensile Strength 
(N/mm
2
) 
Mean dissolution 
time 
 (t50/min) 
Mean Effect
a)
 Mean Effect Mean Effect Mean Effect 
m/M 
11.8/ 
12.0 
0.20
***
 
2.09/ 
1.98 
-0.11
***
 
0.265/ 
0.993 
0.668
***
 
1.99/ 
10.4 
8.40
***
 
d/D 
11.9/ 
11.9 
0.01 
2.03/ 
2.04 
0.01 
0.644/ 
0.554 
-0.090 
8.76/ 
3.63 
-5.13
***
 
md/MD 
11.9/ 
11.8 
-0.13
*
 
2.04/ 
2.04 
0.00 
0.553/ 
0.645 
0.091 
8.76/ 
3.63 
-5.13
***
 
f/F 
11.9/ 
11.9 
0.00 
2.07/ 
2.00 
-0.07
***
 
0.568/ 
0.630 
0.063 
6.16/ 
6.23 
0.068 
mf/MF 
11.9/ 
11.9 
-0.08 
2.02/ 
2.05 
0.03
*
 
0.596/ 
0.602 
0.005 
6.16/ 
6.25 
0.123 
df/DF 
11.9/ 
11.9 
0.01 
2.04/ 
2.04 
0.00 
0.592/ 
0.606 
0.014 
6.13/ 
6.26 
0.128 
mdf/ 
MDF 
11.9/ 
11.9 
0.01 
2.04/ 
2.03 
-0.01 
0.611/ 
0.587 
-0.024 
6.21/ 
6.17 
-0.038 
 
4. DISCUSSION 
The increase of powdered milk fraction in the formulation causes an increase in batches 
weight, thinner harder compacts are produced and a slower dissolution profile is obtained. 
Taking into account paracetamol's well-known poor compressibility behaviour [18], it is no 
surprise that when a raw material such as powdered milk (rich in proteins, lactose and 
lipids) is used in the formulation it shows the ability to improve the API compressibility 
behaviour.  Measurements of compressive strength of powder compacts are sometimes used 
to study the cohesion and caking of dairy powders [19], cylindrical powder plugs are 
produced using low pressures, demonstrating powdered milk good compressibility 
behaviour. Furthermore, results show that increasing fat contents in milk powder's 
a)
 Effect p of significance: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
 
composition promote cohesion and caking, facilitating the obtention compacts [20]. 
Additionally, the melting of fat milk (~40ºC) can promote the formation of fatty bridges 
that when the temperature drops crystallize and increase cohesiveness and caking [21]. At 
high pressures it's possible that due to the increasing temperatures during compression and 
its decrease after tablet's injection fatty bridges crystallization may take place, further 
improving tablets interparticle bonding.  Finally, studies also show that increasing 
moistures content due to absorption of water by lactose and milk proteins result in higher 
cohesiveness, possibly due to plasticization of the powder material or liquid bridging 
occurring due to moisture condensation between particle [20, 22]. However, the last 
phenomenon is more critical for samples with higher contents of lactose and proteins as 
skimmed powdered milk.  As so, powdered milk seems to comprise a series of 
characteristics that could possibly potentiate its use as binder in direct compression. 
Macroscopically it was possible to verify powdered milk utility as a binder, as formulations 
with a higher percentage of paracetamol, contrastingly with the ones with a higher fraction 
of powdered milk, delivered more fragile powdery tablets, raising doubt to their ability to 
withstand further handling.   
Super disintegrants are excipients used to promote rapid breakdown of oral solid dosage 
forms and because they can be present at lower concentrations in the overall formulation 
any possible adverse effect on ﬂuidity or compactibility is minimized [23].  So it is not 
surprising that one's work revealed similar results, where in one hand the increase of 
croscarmellose in the formulations showed to be crucial in promoting the rapid 
desegregation of the mini-tablets and in the other seem to adversely affect powdered milk 
good flowability behaviour [22], producing lighter batches. In dissolution the addition of 
higher fractions of disintegrants seem to be particularly important when powdered milk was 
the main component in the formulation, in fact a marked decrease of nearly 50% in the 
mean dissolution time, was detected when testing it. This may be explained by 
concentration-dependent croscarmellose action [24] and by its effect in disintegration time 
being dependent on the plastic deformation capacity of the powder mixture [25]. 
It is known that compression forces influence tablets proprieties as thickness, porosity, 
crushing strength, friability and disintegration time [26, 27]. However, in this study it was 
only possible to discern a significant influence of the compression force on tablets’ 
thickness. At high pressures crushing strength shows a tendency to level off,  contrary to its  
increase by a power function with increasing pressure, when lower pressures are applied 
[28]. It is also worth to mentioned that at high pressure  particle deformation becomes 
paramour in disintegration due to hindrance of ﬂuid penetration by further reduction of 
porosity [23]. The former may pose an explanation as to why only minor insignificant 
effects for compression force increase and its respective interactions were detected when 
analyzing mini-tablet’s tensile strength and dissolution profile. 
Uniformity of weight and thickness  models show a weaker correlation with the studied 
variables. One possible reason for this is the fact that both responses are highly dependent 
on proper powder rheology and uncountable environmental aspects, such as humidity, 
temperature may have influenced powder characteristics [29], explaining why no better 
adjustment was found. Better, stronger models were found for the mean dissolution time 
and the tensile strength responses. Dissolution rate is highly sensitive test that can be 
influenced by numerous factors related to: the physicochemical properties of the drug 
substance, product formulation, manufacturing processes and factors related to dissolution 
testing conditions [30]. As for the mechanical strength of a tablet it depends on both 
formulation and processing parameter [31]. So, in one hand, it’s no surprise that 
formulation variables correlate so strongly with the mean dissolution time and tensile 
strength and on the other it’s curious to note, as mentioned before, that no quantifiable 
effect was found for the manufacture one,.  
5. CONCLUSION 
Globally the regression equations seem to explain the studied responses with an 
acceptable significance, indicating that formulation variables display a more distinguishable 
influence in the chosen responses than the manufacture, in particular milk/paracetamol 
ratio, which proved to be crucial in the proprieties of the final product. An excipient 
intended for direct compression when added to the formulation should produce tablets with 
enough tensile strength to withstand handling, with low friability and weight variation, a 
short disintegration time and a high drug dissolution rate. Considering the results, it seems 
that powdered milk may prove to be a promising new excipient for the mini-tabletting of 
poor compressible drugs. The predictive mathematical models originated will, hopefully, in 
the future facilitate the pick and choose of the most preferable characteristics when 
producing powdered milk based  mini-tablets for a population as heterogeneous as 
pediatrics. 
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